Babaamaajimowinan (Telling of news in different places)

After ketamine concerns, Hennepin Healthcare will suspend more research studies

A day after suspending its study of the use of ketamine in emergency encounters with agitated people, Hennepin Healthcare said it would halt similar clinical trials that seek consent from patients only after treatment.

Dr. William Heegaard, chief medical officer for the hospital system, appeared before the Hennepin County Board Tuesday to respond to ethical concerns over a ketamine study in which patients are enrolled without their consent.


Reader Comments(0)